RBC Capital analyst Rishi Jaluria lowered the firm’s price target on Palantir to $9 from $15 and keeps an Underperform rating on the shares following a “mixed” Q4 report that shows the company continues to see a broad-based deceleration, led by a slowdown in total deal value and Government segment revenue. Commercial growth excluding investment agreements “continues to be lackluster,” especially given an easier comparison, said Jaluria, who continues to “struggle to underwrite sustainable 30% growth.”
previous post
next post